Dexcom U was created to elevate college athletes with diabetes who are breaking boundaries in sports and achieving their goals, despite their diagnosis. Now through May 23, athletes, coaches ...

Dexcom’s first-of-its-kind NIL program is accepting nominations for passionate and inspiring college athletes with diabetes for its 2025 roster now through May 23. Selected athletes will be ...

The Food and Drug Administration (FDA) has cleared diabetes-management firm DexCom's (DXCM) new continuous glucose monitoring (CGM) system. The San Diego, Calif.-based firm said Thursday that its ...

Dexcom received Food and Drug Administration clearance for a 15-day version of its G7 glucose sensor, the company announced Thursday. Dexcom claims its continuous glucose monitor is the most ...

In addition to improved accuracy, the Dexcom G7 15 Day allows for 15.5 days of wear. The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

Dexcom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, Dexcom has captured an impressive slice ...

That may be one reason why the ability to monitor glucose levels on an Apple Watch became a favorite feature among Dexcom G5 users after its debut in 2015, and since then, many more users have ...

FDA clears Dexcom G7 15-Day CGM for adults, offering 15.5 days of wear and a MARD of 8.0% for improved diabetes management. New features include Apple Watch connectivity, medication logging ...

Investing.com -- Shares of DexCom , Inc. (NASDAQ: DXCM) climbed 9% after the company announced that its Dexcom (NASDAQ:DXCM) G7 15 Day Continuous Glucose Monitoring (CGM) System received FDA ...